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Abstract  Myasthenia  gravis  is  an  autoimmune  disorder  that  is  characterized  by  muscle  weak-
ness that  ﬂuctuates,  worsening  with  exertion,  and  improving  with  rest.  Diagnosis  of  myasthenia
gravis is  made  following  clinical  and  physical  examination  and  is  conﬁrmed  by  serum  immunoas-
says to  measure  autoantibody  levels.  Myasthenia  gravis  especially  when  associated  with
pregnancy  is  a  high-risk  disease,  and  its  course  is  unpredictable.  We  described  the  second
report about  use  of  sugammadex  after  rocuronium  for  a  caesarean  delivery  with  myasthenia
gravis, but,  unlike  our  case  that  formerly  was  diagnosed  with  myasthenia  gravis,  the  patient  was
extubated on  postoperative  successfully  and  we  did  not  encounter  any  respiratory  problems.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
PALAVRAS-CHAVE
Miastenia  grave;
Sugammadex;
Gravidez
O  uso  bem-sucedido  de  sugamadex  para  cesariana  em  paciente  com  miastenia  grave
Resumo  Miastenia  grave  (MG)  é  uma  doenc¸a  autoimune  caracterizada  por  fraqueza  muscular
que ﬂutua,  piorando  com  o  esforc¸o  físico  e  melhorando  com  o  repouso.  O  diagnóstico  de  MG  é
feito após  exame  clínico  e  físico  e  conﬁrmado  por  imunoensaios  séricos  para  medir  os  níveis  de
autoanticorpos.  MG,  especialmente  quando  associada  à  gravidez,  é  uma  doenc¸a  de  alto  risco  e
de curso  imprevisível.  Descrevemos  o  segundo  relato  sobre  o  uso  de  sugamadex  após  rocurônio
para um  parto  cesário  com  miastenia  grave,  mas,  ao  contrário  de  nosso  caso  que  foi  previamente
diagnosticado  com  miastenia  grave,  a  paciente  foi  extubada  com  sucesso  no  pós-operatório  sem
qualquer problema  respiratório.Please  cite  this  article  in  press  as:  Soyoral  L,  et  al.  Successful  u
myasthenia  gravis.  Rev  Bras  Anestesiol.  2014.  http://dx.doi.or
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yasthenia  gravis  (MG)  is  an  autoimmune  disorder  affecting
early  1  million  individuals  worldwide.1 It  is  twice  as  com-
on  among  women  as  it  is  among  men.2 This  autoimmune
isease  is  characterized  by  muscle  weakness  that  ﬂuctuates,
orsening  with  exertion,  and  improving  with  rest.  Diagno-
is  of  MG  is  made  following  clinical  and  physical  examination
nd  is  conﬁrmed  by  serum  immunoassays  to  measure  autoan-
ibody  levels.3,4 Qi  et  al.  concluded  that  pregnant  patients
uffered  from  MG,  with  the  incidence  of  0.023%  in  a  17  year
etrospective  analysis  that  patients  admitted  to  the  hospital
ue  to  pregnancy.5
We  described  the  second  report  about  use  of  sugam-
adex  after  rocuronium  for  a  caesarean  delivery  with  MG,
ut,  unlike  our  case  that  formerly  was  diagnosed  with  MG,
he  patient  was  extubated  on  postoperative  successfully  and
e  did  not  encounter  any  respiratory  problems.
ase
 28-year-old  76  kg  woman  was  admitted  at  39  weeks
f  gestation  (G1P1).  The  Patient  had  been  diagnosed  16
ears  ago  as  MG.  She  used  pyridostigmine  (60  mg/day)
uring  14  years.  Physical  examination  was  normal  except
roximal  upper/lower  extremity  weakness  (3/5).  Anaesthe-
ia  was  induced  with  propofol  (2  mg/kg)  and  rocuronium
0.5  mg/kg).  The  endotracheal  intubation  was  easily
chieved  150  s  after  the  administration  of  rocuronium.
naesthesia  was  maintained  with  sevoﬂurane  (2--2.5%)  and
xygen/air  (40--60%).  A  lively  female  infant  was  born.  Phys-
cal  features  were  normal  (weight:  3300  g,  length:  55  cm,
ead  circumference:  34  cm,  APGAR  score:  6/8/10)  and  did
ot  see  any  signs  of  muscular  hypotonisity.  MG  was  not
bserved  in  the  newborn.  The  newborn  was  admitted  to
eonatal  intensive  care  unit  for  surveillance.  Duration  of  the
peration  was  20  min.  Sugammadex  was  used  (2  mg/kg)  at
he  end  of  the  surgery.  Patient  was  extubated  without  prob-
em  in  2  min  after  sugammadex.  The  patient  was  transferred
o  normal  ward  after  postoperative  1  h  from  recovery  unit.
n  the  third  postpartal  day,  the  patient  could  be  dismissed
n  good  clinical  condition.
iscussion
arcia  et  al.6 described  the  ﬁrst  use  of  sugammadex  after
apid  sequence  induction  using  rocuronium  for  a  caesareanPlease  cite  this  article  in  press  as:  Soyoral  L,  et  al.  Successful  u
myasthenia  gravis.  Rev  Bras  Anestesiol.  2014.  http://dx.doi.or
elivery  in  a  patient  recently  diagnosed  with  MG.  Unfortu-
ately  their  patient  had  persistent  muscle  weakness  that
revented  extubation.  They  concluded  that  myasthenia  may
ave  exacerbated  by  both  surgery  and  the  initiation  of
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reatment.  But,  in  our  case  it  was  extubated  successfully
ithin  2  min  after  administration  of  sugammadex.
Nowadays  authors  recommendation  on  using  sugam-
adex  as  the  new  strategy  of  muscle  relaxant  reversal  seems
o  be  a safe  and  reliable  option  in  patients  with  muscu-
ar  and  neuromuscular  diseases.7 Because  the  main  problem
ies  in  titration  of  neuromuscular  blocking  agents  as  well  as
he  risk  of  anti-cholinesterase  overdose  after  reversal  which
ay  itself  cause  excessive  muscle  weakness  and  need  for
ostoperative  ventilation.8
Berlit  et  al.9 concluded  that  MG  especially  when  associ-
ted  with  pregnancy  is  a  high-risk  disease,  and  its  course
s  unpredictable.  Severe  up  to  life-threatening  conditions
ight  occur  especially  due  to  generalized  weakness,  in  par-
icular  respiratory  insufﬁciency  endangering  the  parturient
s  well  as  the  newborn.
We  concluded  that  a  good  result  can  be  obtained  with
ugammadex  to  reach  the  preoperative  respiratory  effort
n  the  pregnant  patients  with  non-newly  diagnosed  MG  who
ave  preoperative  good  clinical  condition  for  respiratory
unctions  due  to  regularly  received  treatment.
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